Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 20 | 2018 | 778 | 2.200 |
Why?
|
Genetic Therapy | 13 | 2012 | 291 | 2.030 |
Why?
|
Galactosylgalactosylglucosylceramidase | 9 | 2008 | 39 | 1.510 |
Why?
|
Sphingolipids | 12 | 2019 | 337 | 1.300 |
Why?
|
Ceramides | 16 | 2019 | 578 | 1.190 |
Why?
|
Antineoplastic Agents | 13 | 2018 | 1070 | 1.190 |
Why?
|
Acid Ceramidase | 7 | 2020 | 85 | 1.110 |
Why?
|
Apoptosis | 17 | 2020 | 1641 | 1.070 |
Why?
|
Adenoviridae | 11 | 2006 | 295 | 1.040 |
Why?
|
Enzyme Inhibitors | 8 | 2017 | 659 | 1.040 |
Why?
|
Fas Ligand Protein | 11 | 2012 | 64 | 1.010 |
Why?
|
Membrane Glycoproteins | 8 | 2005 | 370 | 0.710 |
Why?
|
Head and Neck Neoplasms | 5 | 2010 | 561 | 0.650 |
Why?
|
Genetic Vectors | 9 | 2008 | 312 | 0.610 |
Why?
|
Cell Line, Tumor | 20 | 2019 | 1851 | 0.570 |
Why?
|
Tumor Cells, Cultured | 6 | 2020 | 852 | 0.560 |
Why?
|
Capsid Proteins | 2 | 2006 | 27 | 0.550 |
Why?
|
Neoplasms | 6 | 2013 | 1667 | 0.480 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2020 | 756 | 0.480 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2006 | 626 | 0.420 |
Why?
|
Cadherins | 1 | 2012 | 93 | 0.400 |
Why?
|
Antigens, CD | 1 | 2012 | 230 | 0.390 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2012 | 135 | 0.380 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 235 | 0.370 |
Why?
|
Desipramine | 2 | 2006 | 47 | 0.350 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2010 | 629 | 0.340 |
Why?
|
Animals | 28 | 2020 | 20881 | 0.340 |
Why?
|
Up-Regulation | 7 | 2012 | 682 | 0.330 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2006 | 45 | 0.280 |
Why?
|
Humans | 45 | 2020 | 68618 | 0.280 |
Why?
|
Cysteine Endopeptidases | 1 | 2006 | 39 | 0.270 |
Why?
|
Propanolamines | 4 | 2013 | 70 | 0.270 |
Why?
|
Bacteriophages | 2 | 2003 | 24 | 0.270 |
Why?
|
Mice, Nude | 8 | 2013 | 294 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2010 | 174 | 0.250 |
Why?
|
Mice | 18 | 2020 | 8474 | 0.250 |
Why?
|
Amides | 3 | 2013 | 86 | 0.250 |
Why?
|
Bacteriophage P1 | 3 | 2003 | 11 | 0.240 |
Why?
|
Escherichia coli | 3 | 2003 | 368 | 0.230 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2005 | 138 | 0.230 |
Why?
|
Male | 23 | 2018 | 37321 | 0.230 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2013 | 304 | 0.220 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2020 | 99 | 0.220 |
Why?
|
Proto-Oncogene Proteins | 3 | 2007 | 411 | 0.220 |
Why?
|
Down-Regulation | 3 | 2012 | 447 | 0.220 |
Why?
|
Bacterial Toxins | 1 | 2003 | 50 | 0.220 |
Why?
|
Escherichia coli Proteins | 1 | 2003 | 65 | 0.210 |
Why?
|
Caspases | 5 | 2007 | 194 | 0.210 |
Why?
|
Bacteriophage M13 | 1 | 2002 | 12 | 0.210 |
Why?
|
Virus Replication | 1 | 2002 | 104 | 0.200 |
Why?
|
Bacterial Infections | 1 | 2003 | 163 | 0.190 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2013 | 35 | 0.190 |
Why?
|
Biomarkers, Tumor | 3 | 2020 | 508 | 0.190 |
Why?
|
RNA, Small Interfering | 4 | 2019 | 434 | 0.180 |
Why?
|
Doxorubicin | 1 | 2002 | 231 | 0.180 |
Why?
|
Blotting, Western | 5 | 2019 | 954 | 0.180 |
Why?
|
Arthritis, Experimental | 1 | 2020 | 38 | 0.180 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 77 | 0.180 |
Why?
|
Chemokine CXCL13 | 2 | 2010 | 8 | 0.180 |
Why?
|
Antigen Presentation | 1 | 2020 | 76 | 0.180 |
Why?
|
Tamoxifen | 1 | 2020 | 62 | 0.170 |
Why?
|
Myristates | 3 | 2008 | 21 | 0.170 |
Why?
|
Lipid Metabolism | 2 | 2018 | 186 | 0.160 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 186 | 0.160 |
Why?
|
Membrane Proteins | 1 | 2003 | 617 | 0.160 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2020 | 282 | 0.160 |
Why?
|
Sphingomyelin Phosphodiesterase | 4 | 2010 | 183 | 0.160 |
Why?
|
Amidohydrolases | 3 | 2007 | 60 | 0.150 |
Why?
|
Myristic Acid | 1 | 2017 | 6 | 0.150 |
Why?
|
Phosphotransferases | 1 | 2017 | 16 | 0.150 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2017 | 26 | 0.150 |
Why?
|
Acyltransferases | 1 | 2017 | 40 | 0.150 |
Why?
|
Mouth Neoplasms | 2 | 2010 | 206 | 0.150 |
Why?
|
Genes, Reporter | 3 | 2006 | 191 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 710 | 0.140 |
Why?
|
Farber Lipogranulomatosis | 1 | 2016 | 5 | 0.140 |
Why?
|
Promoter Regions, Genetic | 4 | 2013 | 615 | 0.130 |
Why?
|
Lysosomes | 2 | 2007 | 136 | 0.130 |
Why?
|
Cell Survival | 4 | 2010 | 901 | 0.130 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2015 | 306 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 284 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2013 | 332 | 0.130 |
Why?
|
Bystander Effect | 2 | 2006 | 10 | 0.120 |
Why?
|
Disease Progression | 3 | 2017 | 1038 | 0.120 |
Why?
|
Transgenes | 2 | 2006 | 92 | 0.120 |
Why?
|
Sphingosine | 6 | 2015 | 315 | 0.120 |
Why?
|
fas Receptor | 2 | 2005 | 54 | 0.120 |
Why?
|
Ligands | 3 | 2005 | 317 | 0.120 |
Why?
|
Radiation Tolerance | 1 | 2013 | 30 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2003 | 100 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2012 | 369 | 0.110 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 3 | 2003 | 65 | 0.110 |
Why?
|
Cytoplasm | 1 | 2013 | 155 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2015 | 332 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 446 | 0.110 |
Why?
|
RNA Interference | 3 | 2010 | 266 | 0.110 |
Why?
|
PTEN Phosphohydrolase | 1 | 2013 | 108 | 0.110 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2003 | 50 | 0.110 |
Why?
|
Catenins | 1 | 2012 | 8 | 0.100 |
Why?
|
Lysophospholipids | 5 | 2015 | 209 | 0.100 |
Why?
|
RANK Ligand | 2 | 2010 | 73 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2013 | 305 | 0.100 |
Why?
|
Cytokines | 1 | 2016 | 866 | 0.100 |
Why?
|
Mortierella | 1 | 2011 | 1 | 0.100 |
Why?
|
Cytoskeleton | 1 | 2012 | 84 | 0.100 |
Why?
|
Genome, Fungal | 1 | 2011 | 6 | 0.100 |
Why?
|
Cell Movement | 2 | 2012 | 630 | 0.100 |
Why?
|
Breast Neoplasms | 2 | 2020 | 1536 | 0.100 |
Why?
|
Ceramidases | 3 | 2007 | 47 | 0.100 |
Why?
|
Cell Death | 1 | 2012 | 329 | 0.100 |
Why?
|
Laryngeal Neoplasms | 1 | 2012 | 47 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 331 | 0.100 |
Why?
|
Adenocarcinoma | 1 | 2013 | 475 | 0.090 |
Why?
|
Osteolysis | 1 | 2010 | 15 | 0.090 |
Why?
|
Lipids | 1 | 2011 | 298 | 0.090 |
Why?
|
Interleukins | 1 | 2010 | 79 | 0.090 |
Why?
|
Viral Proteins | 2 | 2007 | 150 | 0.080 |
Why?
|
Prostate | 1 | 2009 | 116 | 0.080 |
Why?
|
Enzyme Activation | 2 | 2008 | 791 | 0.080 |
Why?
|
Cell Line | 5 | 2020 | 1752 | 0.080 |
Why?
|
Gene Expression | 2 | 2013 | 770 | 0.080 |
Why?
|
Cell Division | 2 | 2020 | 541 | 0.080 |
Why?
|
Carcinoma | 1 | 2010 | 215 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2010 | 742 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2007 | 231 | 0.080 |
Why?
|
Chicken anemia virus | 1 | 2008 | 5 | 0.080 |
Why?
|
Adenovirus E1A Proteins | 1 | 2007 | 6 | 0.080 |
Why?
|
Flow Cytometry | 3 | 2019 | 489 | 0.070 |
Why?
|
Mitochondria | 1 | 2012 | 643 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2006 | 376 | 0.070 |
Why?
|
Indicators and Reagents | 1 | 2007 | 63 | 0.070 |
Why?
|
Subcellular Fractions | 1 | 2007 | 92 | 0.070 |
Why?
|
Antibodies | 2 | 2005 | 241 | 0.070 |
Why?
|
Mitochondrial Membranes | 1 | 2007 | 45 | 0.070 |
Why?
|
Membrane Potentials | 1 | 2007 | 200 | 0.070 |
Why?
|
Signal Transduction | 4 | 2013 | 2689 | 0.070 |
Why?
|
Hyaluronan Receptors | 1 | 2008 | 142 | 0.070 |
Why?
|
Phosphoserine | 1 | 2006 | 14 | 0.070 |
Why?
|
Endosomes | 1 | 2006 | 45 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 236 | 0.070 |
Why?
|
Hyaluronic Acid | 1 | 2008 | 206 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 1753 | 0.070 |
Why?
|
Hydrolysis | 1 | 2006 | 144 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 337 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2007 | 271 | 0.070 |
Why?
|
Cell Cycle | 2 | 2020 | 312 | 0.070 |
Why?
|
Protein Transport | 1 | 2006 | 280 | 0.060 |
Why?
|
Dinoprostone | 1 | 2006 | 110 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2007 | 618 | 0.060 |
Why?
|
Plasmids | 2 | 2003 | 258 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2005 | 4 | 0.060 |
Why?
|
Recoverin | 1 | 2005 | 3 | 0.060 |
Why?
|
Viral Vaccines | 1 | 2005 | 17 | 0.060 |
Why?
|
Cytosine Deaminase | 1 | 2005 | 8 | 0.060 |
Why?
|
Thymidine Kinase | 1 | 2005 | 18 | 0.060 |
Why?
|
Immunotherapy | 1 | 2007 | 215 | 0.060 |
Why?
|
Genes, p53 | 1 | 2005 | 41 | 0.060 |
Why?
|
Antigens, Surface | 1 | 2005 | 71 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2005 | 511 | 0.060 |
Why?
|
Cell Membrane | 1 | 2006 | 525 | 0.060 |
Why?
|
DNA, Bacterial | 2 | 2002 | 150 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2005 | 114 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 2 | 2002 | 111 | 0.060 |
Why?
|
Mucins | 1 | 2004 | 22 | 0.060 |
Why?
|
Female | 7 | 2020 | 38074 | 0.060 |
Why?
|
Lipoproteins | 1 | 2005 | 161 | 0.060 |
Why?
|
Eye Proteins | 1 | 2005 | 160 | 0.060 |
Why?
|
Gram-Positive Cocci | 1 | 2003 | 5 | 0.060 |
Why?
|
Mice, Inbred ICR | 1 | 2003 | 44 | 0.060 |
Why?
|
Dexamethasone | 1 | 2004 | 150 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2003 | 59 | 0.050 |
Why?
|
Caspase Inhibitors | 1 | 2003 | 36 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2003 | 41 | 0.050 |
Why?
|
Complement System Proteins | 1 | 2004 | 135 | 0.050 |
Why?
|
Hot Temperature | 1 | 2003 | 152 | 0.050 |
Why?
|
Mathematical Computing | 1 | 2002 | 12 | 0.050 |
Why?
|
Spleen | 1 | 2003 | 301 | 0.050 |
Why?
|
Lymphocytes | 1 | 2003 | 228 | 0.050 |
Why?
|
Glioma | 1 | 2003 | 140 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 216 | 0.050 |
Why?
|
Structure-Activity Relationship | 2 | 2017 | 420 | 0.050 |
Why?
|
Transformation, Genetic | 1 | 2002 | 14 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2003 | 597 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 2 | 2017 | 194 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2002 | 22 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2004 | 222 | 0.050 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2002 | 22 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 261 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 848 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 39 | 0.050 |
Why?
|
Androgens | 1 | 2002 | 41 | 0.050 |
Why?
|
Cell Count | 1 | 2002 | 248 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2002 | 55 | 0.050 |
Why?
|
DNA, Viral | 1 | 2002 | 114 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2013 | 71 | 0.050 |
Why?
|
Transduction, Genetic | 3 | 2010 | 81 | 0.050 |
Why?
|
Pseudomonas aeruginosa | 1 | 2002 | 133 | 0.050 |
Why?
|
Phosphorylation | 2 | 2017 | 1200 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2015 | 201 | 0.050 |
Why?
|
HLA-DR4 Antigen | 1 | 2020 | 11 | 0.050 |
Why?
|
Base Sequence | 4 | 2003 | 1015 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 1293 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2020 | 1174 | 0.050 |
Why?
|
Cathepsins | 1 | 2020 | 37 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2020 | 120 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 50 | 0.050 |
Why?
|
Transcriptional Activation | 2 | 2013 | 226 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2003 | 371 | 0.040 |
Why?
|
A549 Cells | 1 | 2019 | 50 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 226 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2020 | 329 | 0.040 |
Why?
|
Cisplatin | 1 | 2019 | 192 | 0.040 |
Why?
|
Models, Biological | 1 | 2002 | 981 | 0.040 |
Why?
|
Combinatorial Chemistry Techniques | 2 | 2007 | 25 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2017 | 137 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2007 | 111 | 0.040 |
Why?
|
Stereoisomerism | 2 | 2007 | 169 | 0.040 |
Why?
|
Survival Rate | 1 | 2020 | 1056 | 0.040 |
Why?
|
Mice, SCID | 1 | 2017 | 238 | 0.040 |
Why?
|
Hexosaminidases | 1 | 2016 | 7 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2017 | 112 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2017 | 2673 | 0.040 |
Why?
|
Macrophages | 1 | 2020 | 647 | 0.030 |
Why?
|
Arthritis, Juvenile | 1 | 2016 | 70 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2017 | 326 | 0.030 |
Why?
|
Molecular Structure | 2 | 2007 | 397 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 149 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2015 | 2550 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 122 | 0.030 |
Why?
|
Adamantane | 1 | 2015 | 40 | 0.030 |
Why?
|
Protein Isoforms | 2 | 2007 | 246 | 0.030 |
Why?
|
Prognosis | 1 | 2020 | 2093 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2007 | 532 | 0.030 |
Why?
|
Gene Transfer Techniques | 2 | 2008 | 173 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 206 | 0.030 |
Why?
|
Karyopherins | 1 | 2013 | 11 | 0.030 |
Why?
|
Pyridines | 1 | 2015 | 261 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2013 | 55 | 0.030 |
Why?
|
Taxoids | 1 | 2013 | 41 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2013 | 89 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2013 | 61 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2013 | 119 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 160 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 66 | 0.030 |
Why?
|
Transfection | 2 | 2008 | 782 | 0.030 |
Why?
|
Lac Operon | 2 | 2003 | 54 | 0.030 |
Why?
|
Carbocyanines | 1 | 2012 | 13 | 0.030 |
Why?
|
Luminescent Proteins | 2 | 2003 | 57 | 0.030 |
Why?
|
Cytochromes c | 1 | 2012 | 75 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2012 | 81 | 0.030 |
Why?
|
Coloring Agents | 1 | 2012 | 66 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 223 | 0.030 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 77 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2012 | 83 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2012 | 93 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2003 | 200 | 0.030 |
Why?
|
Reproduction, Asexual | 1 | 2011 | 1 | 0.030 |
Why?
|
Lipogenesis | 1 | 2011 | 9 | 0.030 |
Why?
|
Dependovirus | 1 | 2012 | 34 | 0.030 |
Why?
|
Genome, Mitochondrial | 1 | 2011 | 12 | 0.020 |
Why?
|
Fungal Proteins | 1 | 2011 | 37 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 381 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2011 | 144 | 0.020 |
Why?
|
Multigene Family | 1 | 2011 | 93 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2012 | 128 | 0.020 |
Why?
|
DNA Primers | 2 | 2002 | 302 | 0.020 |
Why?
|
Optical Imaging | 1 | 2012 | 46 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2012 | 258 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2011 | 188 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 2791 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 322 | 0.020 |
Why?
|
Phylogeny | 1 | 2011 | 197 | 0.020 |
Why?
|
Fatty Acids | 1 | 2011 | 222 | 0.020 |
Why?
|
Protein Binding | 1 | 2013 | 1027 | 0.020 |
Why?
|
Chemotaxis | 1 | 2010 | 38 | 0.020 |
Why?
|
Fumonisins | 1 | 2010 | 14 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2003 | 1447 | 0.020 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2010 | 29 | 0.020 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2010 | 17 | 0.020 |
Why?
|
Protein Phosphatase 2 | 1 | 2010 | 67 | 0.020 |
Why?
|
Sphingomyelins | 1 | 2010 | 106 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2009 | 40 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 160 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2010 | 148 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2010 | 215 | 0.020 |
Why?
|
Paclitaxel | 1 | 2008 | 140 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2009 | 202 | 0.020 |
Why?
|
Tumor Protein p73 | 1 | 2007 | 4 | 0.020 |
Why?
|
Integrases | 1 | 2008 | 31 | 0.020 |
Why?
|
Drug Design | 1 | 2008 | 107 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2010 | 1174 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 176 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2007 | 120 | 0.020 |
Why?
|
Larynx | 1 | 2007 | 49 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2007 | 61 | 0.020 |
Why?
|
Pharynx | 1 | 2007 | 89 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2007 | 274 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2007 | 284 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2007 | 132 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2010 | 1034 | 0.020 |
Why?
|
Vaccination | 1 | 2007 | 189 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2008 | 299 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 753 | 0.020 |
Why?
|
Nanoparticles | 1 | 2008 | 254 | 0.020 |
Why?
|
Clusterin | 1 | 2004 | 13 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 546 | 0.010 |
Why?
|
Complement Inactivator Proteins | 1 | 2004 | 20 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2004 | 66 | 0.010 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2003 | 18 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 32 | 0.010 |
Why?
|
Caspase 8 | 1 | 2003 | 40 | 0.010 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2003 | 19 | 0.010 |
Why?
|
Astrocytoma | 1 | 2003 | 30 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 700 | 0.010 |
Why?
|
Operator Regions, Genetic | 1 | 2003 | 5 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2004 | 81 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2007 | 1553 | 0.010 |
Why?
|
Fibroblasts | 1 | 2007 | 902 | 0.010 |
Why?
|
Glycoproteins | 1 | 2004 | 238 | 0.010 |
Why?
|
Restriction Mapping | 1 | 2002 | 85 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2003 | 183 | 0.010 |
Why?
|
Middle Aged | 1 | 2020 | 21147 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 4655 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 307 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 357 | 0.010 |
Why?
|
Caspase 3 | 1 | 2002 | 233 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 562 | 0.010 |
Why?
|